
Brendan Chang
@tshcw
@UFPharmacy 🐊 TW made🇹🇼
ID: 1441095620744204292
23-09-2021 17:42:51
7 Tweet
15 Followers
34 Following

New publication by UF Center for Drug Evaluation and Safety trainee XinyiJiang11 in American Journal of Preventive Medicine (AJPM) - Economic Impact of #UniversalHepatitisC Virus Testing for Middle-Aged Adults Who Inject Drugs Jenny Lo-Ciganic @VouriPharmD @tshcw #Dr. Haesuk Park sciencedirect.com/science/articl…

Now available in Annals of Oncology, the ESMO - Eur. Oncology Clinical Practice Guideline for the diagnosis and management of venous thromboembolism in patients with cancer annalsofoncology.org/article/S0923-…


Role of Immunotherapy in #breastcancer ascopubs.org/doi/pdf/10.120… JCO Oncology Practice Journal of Clinical Oncology Excellent review article by Hope Rugo OncoAlert


New review from Ticiana Batista (Leal) et al | Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non–small cell lung cancer 🔗 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #LCSM


New publication by #Dr. Haesuk Park in #PharmacoepidemiolDrugSaf - Association between Treatment of #HepatitisCVirus and Risk of #CardiovascularDisease Among Insured Patients With Virus in the U.S. @tshcw UF Pharmacy pubmed.ncbi.nlm.nih.gov/37278688/

New publication by UF Center for Drug Evaluation and Safety trainee Brendan Chang in AMCP– Cost-effectiveness of early vs delayed use of abemaciclib combination therapy for patients with high-risk hormone receptor–positive/human epidermal growth factor... jmcp.org/doi/10.18553/j…